Medicare Benefits Schedule - Item 73301

Search Results for Item 73301

Category 6 - PATHOLOGY SERVICES

73301

73301 - Additional Information

Item Start Date:
01-Aug-2020
Description Updated:
01-Aug-2020
Schedule Fee Updated:
01-Aug-2020

Group
P7 - Genetics

A test of tumour tissue from a patient with advanced (FIGO III-IV), high-grade serous or high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer, requested by a specialist or consultant physician, to determine eligibility relating to BRCA status for access to olaparib under the Pharmaceutical Benefits Scheme (PBS).

 

Applicable once per primary tumour diagnosis

Fee: $1,200.00 Benefit: 75% = $900.00 85% = $1,112.10


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change